series-c-plus
Stage
1
Investors
About
Flarin is a pharmaceutical company that produces a patented lipid-formulated ibuprofen product designed to provide effective relief from joint, muscular, and arthritic pain. The formulation allows for better absorption and stomach protection compared to standard ibuprofen.
Explore Flarin's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.